http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RS-54416-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5176dd638294e47a46f6b25df6ce35f6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2010-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_115ea6567b30b59de263ac8bca0e4482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7efe9f470e077e47fbfe8e6ed634ab44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c17666036db8e0fd8291345b502f18d9
publicationDate 2016-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RS-54416-B1
titleOfInvention ROSTAFUROXIN FOR PHARMACOGENOMIC TREATMENT OF CARDIOVASCULAR STATES
abstract Rostafuroxin for use in treating or preventing a cardiovascular condition in an individual wherein said selected individual is carrying at least one polymorphism selected from the group consisting of rs2345088, rs16877182, rs16893522, rs246191 1, rs5013093, and rs12513375 sec for SEK, respectively : 11, ID BR SEK: 1, ID BR SEK: 9, ID BR SEK: 5, ID BR SEK: 3 and ID BR SEK: 7, and at least one selected genotype is from a group consisting of the TT genotype for rs2345088, heterozygous genotype C / T for rs16877182, genotype AA for rs16893522, genotype AA for rs246191 1, TT genotype for rs5013093, and TT genotype for rs12513375. The application contains 16 more claims.
priorityDate 2009-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415854672

Total number of triples: 34.